Conference Reports for NATAP

Conference on Retroviruses and Opportunistic Infections (CROI) February 13-16, 2017, Seattle WA Back

Doravirine in Non-Inferior To Darunavir+Ritonavir in Phase 3 Treatment-Naive Trial at Week 48       Reported by Jules Levin CROI 2017 Feb 14-17 Seattle, WA   WEBCAST: http://www.croiwebcasts.org/console/player/33382?mediaType=slideVideo&